MHRA assesses cost to industry of complying with new law on falsified medicines
24 January 2012
Ian Schofield
Please Login to read the full article.
24 January 2012
Ian Schofield
Please Login to read the full article.
RELATED CONTENT
NEWS
- New EU anti-counterfeiting rules: comprehensive but costly
- European industry bodies voice concern over CoE's anti-counterfeiting system
- Deadline looms for proposals on "safety features" for product packs in EU
- Anti-counterfeiting: UK regulator clashes with EC and industry over mandatory checks
FEATURES
- DKSH highlights one-stop benefits as it builds Asia market expansion services
- Merck BioVentures: where biosimilars make a difference
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
